Home

Brett R. Hagen, Chief Accounting Officer: Kalaris Therapeutics KLRS Sell · Filed 24/01/02

Trade details

Type
Insider sale
Amount
$20,967.9
Shares · price
28,335 sh · $0.74 a share
Held after
97,500 sh
Trade date
23/12/27
Filed
24/01/02
Days to filing
6 days

Sold 22.5% of holdings

Share of holding sold
22.5%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/27~24/01/26

Brett R. Hagen's recent trades

  • Brett R. Hagen

    SellKalaris Therapeutics

    $12.9K

    Filed 03/23

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $12.9K

    Filed 03/20

  • Brett R. Hagen

    SellKalaris Therapeutics

    $8,136

    Filed 25/03/27

  • Brett R. Hagen

    SellKalaris Therapeutics

    $968

    Filed 25/02/24

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $967

    Filed 25/02/24